Wordt geladen...
Ticagrelor: An investigational oral antiplatelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome
Acute coronary syndromes (ACS) are the leading cause of mortality and one of the main reasons for hospital admissions in the developed nations. Due to high rates of mortality and reinfarction, ACS represent a major public health concern. Platelets play a central role in atherothrombosis, the main pa...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2964949/ https://ncbi.nlm.nih.gov/pubmed/21057581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S13263 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|